Cardiac rehabilitation for young cancer survivors
Official title: The Harmonized Interventions to Maintain Health Via Appropriate Risk Factor Modification and Lifestyle Changes in Pediatric, Adolescent and Young Adult Cancer Survivors Study: A Multicentre Randomized Controlled Trial
Run by University Health Network, Toronto · NCT05023785 · Data updated 2026-11-12
This study tests a special exercise program for young cancer survivors to see if it can help improve their heart health and overall fitness.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | All |
| Enrollment | 336 (estimated) |
| Sponsor | University Health Network, Toronto Academic / other |
| Drugs / interventions | trastuzumab |
| Locations | 1 site (Toronto, Ontario) |
| Status | Recruiting |
| Started | January 1, 2024 |
| Main results expected | September 2026 |
| Study ends | March 2027 |
| Registry record updated | November 26, 2025 |
| Trial ID | NCT05023785 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are cancer survivors aged 18-45 who were diagnosed with cancer before age 40 and have experienced treatment-related cardiovascular risks.
✕Probably not a fit
Patients who are currently undergoing cancer treatment or those with advanced heart failure may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial evaluates the effectiveness of a Cardio-Oncology Rehabilitation (CORE) program for pediatric, adolescent, and young adult cancer survivors who are at increased risk of cardiovascular issues due to their cancer treatments. Participants will engage in a six-month structured exercise program that includes both home and onsite training, aimed at improving their cardiovascular health and overall fitness. The study will assess changes in physical fitness, cardiac function, and psychosocial well-being among participants. By focusing on non-pharmacological interventions, this trial seeks to address the unique health challenges faced by this underserved population.
Why it matters
Potential benefit: If successful, this intervention could significantly improve cardiovascular health and quality of life for young cancer survivors.
How similar studies have gone: Previous studies have shown promise in using exercise and rehabilitation programs for improving cardiovascular outcomes in cancer survivors, indicating that this approach is both relevant and potentially effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria:
1. Be a PAYA-CS, defined as ≤39 years of age at the time of cancer diagnosis;
2. Be 18-45 years of age at the time of enrolment;
3. Received cancer treatment(s) with known cardiovascular risks (e.g., anthracyclines, trastuzumab, radiotherapy, platinum-based agents, vascular endothelial growth factor inhibitors, tyrosine kinase inhibitors);
4. Be cancer-free at the time of enrollment;
5. Stage B Heart Failure (SBHF)
* In patients with availability of pre-treatment imaging:
* ≥10% decrease in LVEF at post-treatment compared to pre-treatment
* ≥15% decrease in GLS at post-treatment compared to pre-treatment
* No pre-treatment imaging:
* LVEF ≤53% in women/51% in men
* GLS \>-18%
* Left ventricular hypertrophy (LV mass/body surface area: \>95 g/m2 for women or \>115 g/m2 for men)
* Concentric remodelling (\>0.42 relative wall thickness)
* Diastolic dysfunction (≥ grade 1)
* BNP ≥35pg/ml or NT-proBNP ≥125pg/ml
Exclusion Criteria:
1. Have an absolute or unresolved relative contraindication to exercise according to the American College of Sports Medicine guidelines;
2. Have an untreated physical or mental health concern that precludes safe and effective exercise participation;
3. Have established CVD (excluding mildly reduced LVEF as described above);
4. Be pregnant at time of recruitment;
5. Be currently engaging in frequent high-intensity exercise (\>1 high-intensity exercise session per week);
6. Have substantial barriers to participating, including (1) living too far from study centre or (2) being unable or willing to comply with the study protocol.
Where it's running
-
University Health Network
Toronto, Ontario, Canada Recruiting
Study contacts
- Study coordinator: Paaladinesh Thavendiranathan, MD
- Email: dinesh.thavendiranathan@uhn.ca
- Phone: 416-340-5326
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Machine-learning prediction of heart damage from anthracycline or HER2 cancer therapies
We will see if a machine-learning score can predict which adults starting anthracycline or HER2-targeted cancer therapies will develop heart damage within one year.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
AI-based assessment of heart function using ECG wearable monitors
This study tests if a new AI tool using a wearable heart monitor can accurately check heart function in people with heart failure compared to traditional heart scans.
-
Exercise and fitness program for breast cancer survivors to improve heart health
This study tests whether a special exercise and yoga program can help breast cancer survivors over 60 improve their heart health and physical fitness after treatment.
-
Stopping heart failure medications in cancer survivors with heart dysfunction
This study is testing if cancer survivors with improved heart function can safely stop taking their heart failure medications to see if it reduces their pill burden and side effects.
-
Long-term effects of breast cancer treatment on heart function
This study looks at how breast cancer treatments affect heart health in women who survived breast cancer to see if any heart problems they had in the past might get worse over time.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.